Financial Grants, Conference Calls, New Manufacturing Facilities, Dividends, and Share Repurchase Programs - Analyst Notes on Rockwell, The Babcock & Wilcox, ABB, Actuant and Nordson

NEW YORK, June 11, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Rockwell Automation Inc. (NYSE: ROK), The Babcock & Wilcox Company (NYSE: BWC), ABB Ltd. (NYSE: ABB), Actuant Corporation (NYSE: ATU) and Nordson Corporation (NASDAQ: NDSN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3585-100free.

Rockwell Automation Inc. Analyst Notes
On June 4, 2014, Rockwell Automation Inc. (Rockwell) announced that the Board of Directors has authorized the Company to expend up to an additional $1 billion to repurchase shares of Rockwell common stock. This is in addition to the authorization to repurchase $1 billion worth of common stock, given on June 8, 2012, of which approximately $223 million was remaining as of June 3, 2014. Further, the Board has also declared a quarterly dividend in the amount of $0.58 per share on common stock. The dividend is payable on September 10, 2014, to shareholders of record at the close of the business on August 11, 2014. The full analyst notes on Rockwell are available to download free of charge at:

http://www.analystsreview.com/Jun-11-2014/ROK/report.pdf

The Babcock & Wilcox Company Analyst Notes
On June 6, 2014, Babcock & Wilcox Co.'s (Babcock & Wilcox) stock increased slightly by 1.14% to end the day at $32.78. The Company's stock increased 2.89% over the past three trading days, compared to the Dow Jones Industrial Average which rose 1.21% and to S&P 500 which gained 1.31% during the same trading period. The full analyst notes on The Babcock & Wilcox are available to download free of charge at:

http://www.analystsreview.com/Jun-11-2014/BWC/report.pdf

ABB Ltd. Analyst Notes
On June 6, 2014, ABB Ltd. (ABB) announced that it has made a grant worth 5 million Swiss Francs to the ETH Zurich Foundation. The grant, which will be distributed over a period of 10 years, aims to support the development of high-performance power semiconductors to improve the efficiency of power conversion systems and energy transmission over long distances as well as industrial solutions. "We're honored to contribute to this new professorship at ETH Zurich (Swiss Federal Institute of Technology) and are convinced this undertaking will pay dividends in the development of the electricity network of the future," said ABB CEO Ulrich Spiesshofer. "We need to decouple economic growth from energy consumption. This contribution underscores ABB's commitment to power and productivity for a better world." The full analyst notes on ABB are available to download free of charge at:

http://www.analystsreview.com/Jun-11-2014/ABB/report.pdf

Actuant Corporation Analyst Notes
On May 30, 2014, Actuant Corp. (Actuant) announced its conference call schedule in relation to Q3 FY 2014 earnings. The Company intends to webcast its earnings conference call reporting its financial results on June 18, 2014, Wednesday, beginning at 10:00 a.m. CT. Further, the Company also announced the completion of Hayes Industries, Ltd (Hayes) acquisition for approximately $31 million plus potential future performance related consideration. The full analyst notes on Actuant are available to download free of charge at:

http://www.analystsreview.com/Jun-11-2014/ATU/report.pdf

Nordson Corporation Analyst Notes
On June 2, 2014, Nordson Corp. (Nordson) announced the groundbreaking of a new state-of-the-art manufacturing facility in Loveland, Colorado. The new manufacturing facility aims to meet the growing demand in medical end markets for Nordson's Value Plastics brand of engineered, single-use plastic-molded fluid management components. Nordson believes that the Colorado facility will provide flexibility and capacity for continued long term growth. "We continue to see outstanding global growth opportunities for innovative components, devices and custom OEM solutions related to precision fluid management and delivery of biomaterials," said George Porter, Nordson Vice President and General Manager for Medical Product Lines. "This new facility reflects Nordson's ongoing commitment and investment to meeting our medical customers' needs at the highest level." The Company expects that full operations will commence in H1 2015. The full analyst notes on Nordson are available to download free of charge at:

http://www.analystsreview.com/Jun-11-2014/NDSN/report.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review